Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PMN | US
-0.04
-4.05%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.95
0.95
1.02
0.92
ProMIS Neurosciences Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310 a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267 a TDP-43; and PMN442 a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences Inc. in July 2015. ProMIS Neurosciences Inc. was incorporated in 2004 and is headquartered in Toronto Canada.
View LessLow Market Beta (-0.4 to 0.8)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
46.3%1 month
57.0%3 months
93.8%6 months
88.7%-
-
300.04
-
-
-1.74
3.87K
-
-11.15M
28.39M
28.39M
-
-
-
-
-1.10K
1.98
0.56
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.22
Range1M
0.53
Range3M
1.28
Rel. volume
1.20
Price X volume
76.24K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| DarT Bioscience Inc | DARE | Biotechnology | 3.635 | 31.07M | -2.55% | 0.12 | 218.34% |
| Surrozen Inc. Common Stock | SRZN | Biotechnology | 9.38 | 30.07M | -5.06% | n/a | 35.73% |
| Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 2.09 | 30.01M | -4.57% | n/a | 11.72% |
| Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 1.58 | 29.31M | -0.63% | n/a | 571.64% |
| Nuo Therapeutics Inc | AURX | Biotechnology | 0.6216 | 28.97M | 0.00% | n/a | 0.00% |
| Kala Pharmaceuticals Inc | KALA | Biotechnology | 5.24 | 28.72M | 0.77% | n/a | 268.29% |
| NRXBF | NRXBF | Biotechnology | 0.4014 | 28.59M | 3.72% | n/a | 0.00% |
| BriaCell Therapeutics Corp. Common Shares | BCTX | Biotechnology | 0.7962 | 28.57M | -5.17% | n/a | 0.00% |
| iBio Inc | IBIO | Biotechnology | 3.09 | 28.24M | 7.67% | n/a | 20.92% |
| SABS | SABS | Biotechnology | 3.05 | 28.15M | 1.33% | n/a | 11.58% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
| ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
| Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.74 | - | Cheaper |
| Ent. to Revenue | 3,868.08 | - | Par |
| PE Ratio | - | 41.03 | - |
| Price to Book | 300.04 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 93.78 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 28.39M | - | Emerging |